Sun Pharma

News

SUN PHARMA NEWS

Australia's Mayne Pharma sues Indian drugmaker Sun Pharma over patent infringement

July 25, 2024 6:07 pm

The Australian drugmaker said it filed the lawsuit after a notification indicated Sun Pharma's submission of an Abbreviated New Drug Application (ANDA) to the FDA seeking approval to market a generic version of IMVEXXY.

Sun Pharma's shares were sold at an average price of Rs 973.80 per share during the period through an open market sale in an ordinary course of transaction, LIC said.

LIC sells over 2% stake in Sun Pharma for Rs 4,699 crore

September 14, 2023 4:40 pm

LIC on Thursday said it has sold 2 per cent of its holding in Sun Pharma for Rs 4,699 crore via open market sale.

Sun Pharma, Alembic recall drugs in US market

July 30, 2023 11:50 am

New Jersey-based Sun Pharmaceutical Industries Inc is recalling 7,313 bottles of Methylphenidate Hydrochloride tablets due to the "presence of foreign substance: metal embedded in a tablet", the USFDA stated.

Sun Pharma posts consolidated net profit of Rs 1,984 crore in Q4

May 26, 2023 4:46 pm

Excluding the exceptional items, adjusted net profit for the fourth quarter last fiscal stood at Rs 2,156 crore, up 36 per cent, over the fourth quarter of 2021-22 fiscal, Sun Pharma said in a regulatory filing.

Sun Pharma says revenue may decline as operations hit due to ransomware attack

March 27, 2023 10:07 am

On March 2, Sun Pharma said an information technology security incident has occurred.

USFDA pulls up Sun Pharma for lapses in Halol plant

January 15, 2023 7:07 am

In a warning letter, the US Food and Drug Administration pointed out various lapses at the Halol plant which produces finished pharmaceutical products.

Delhi HC slaps Rs 10 lakh cost on Sun Pharma for concealment of facts in trademark infringement case

November 24, 2022 11:05 am

Sun Pharma had moved to restrain DWD Pharmaceuticals Ltd from infringing on its ‘FORZEST’ trademark by selling medicines under the trademark ‘FOLZEST’. While FORZEST is used to target erectile dysfunction, FOLZEST is a multivitamin for pregnant women

Dilip Shanghvi resigns as MD of SPARC

May 26, 2021 2:05 pm

Shanghvi expressed his desire to step down and tendered his resignation as the MD with immediate effect, which was accepted by the board, Sun Pharma Advanced Research Company (SPARC) said in a regulatory filing.